TNYA
TNYA
NASDAQ · Biotechnology

Tenaya Therapeutics Inc

$0.39
+0.03 (+9.38%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +9,075.1% upside
Low Target $26.32
Average Target $36.15
High Target $48.95
Current Price $0.39
Current
$0.39
Target
$36.15
$26.32 $36.15 avg $48.95
Scenario Analysis
Bear Case
$26.32
6,580.2%
Low target
Base Case
$36.15
+9,075.1%
Avg target
Bull Case
$48.95
+12,323.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.56
-74.7% from high
52-Week Low
$0.30
+31.3% from low
Target vs 52W High
$36.15
+2,217.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%